PTPRC and pulmonary arterial hypertension: During pulmonary arterial hypertension, CCL5 expression was associated with CD45+ inflammatory cell infiltration into the pulmonary artery wall, and CCL5 deletion attenuated Sugen5416/hypoxia-induced pulmonary arterial hypertension and pulmonary vascular remodeling 38, 39.